Differential clathrin binding and subcellular localization of OCRL1 splice isoforms.

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• OCRL1 mutations cause Lowe syndrome, affecting brain, kidney, and eye development.
• OCRL1 has two splice isoforms (a and b) differing by 8 amino acids.
• The functional significance of OCRL1 splicing and its impact on protein interactions remain unclear.

Purpose of the Study:

• To investigate the impact of OCRL1 splicing on its interaction with clathrin.
• To determine how OCRL1 isoforms differ in their association with clathrin-coated vesicles.
• To elucidate the role of OCRL1 in clathrin-mediated endocytosis.

Main Methods:

• Comparative analysis of clathrin binding affinity between OCRL1 isoforms a and b.
• Immunofluorescence and biochemical assays to detect enrichment in clathrin-coated trafficking intermediates.
• Functional assays examining transferrin endocytosis in cells expressing OCRL1 variants.
• Investigation of OCRL1 interaction with Rab GTPases and AP2.

Main Results:

• OCRL1 isoform a exhibits higher affinity for clathrin compared to isoform b.
• Isoform a is significantly more enriched in clathrin-coated trafficking intermediates.
• A second clathrin-binding site was identified in OCRL1.
• OCRL1 association with clathrin-coated intermediates depends on membrane association via Rab GTPases, not AP2.
• Expression of OCRL1 isoform a lacking the 5-phosphatase domain impairs transferrin endocytosis, unlike isoform b.

Conclusions:

• OCRL1 splicing generates two functional pools with distinct roles in clathrin-mediated trafficking.
• Isoform a plays a significant role in clathrin-mediated endocytosis, while isoform b has a lesser or no role.
• These findings provide insights into the molecular mechanisms underlying Lowe syndrome and cellular trafficking pathways.